Results 191 to 200 of about 16,277,273 (324)

Pertinent Negatives [PDF]

open access: yesJournal of General Internal Medicine, 2021
openaire   +2 more sources

Positive and Negative Regulation of Gli Activity by Kif7 in the Zebrafish Embryo

open access: gold, 2013
Ashish K. Maurya   +10 more
openalex   +2 more sources

Structural assignment of isomeric 2‐aminopyridine‐derivatized monosialylated biantennary N‐linked oligosaccharides using negative‐ion multistage tandem mass spectral matching [PDF]

open access: bronze, 2005
Kisaburo Deguchi   +7 more
openalex   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

open access: yesMolecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed   +10 more
wiley   +1 more source

ANCA-Negative Wegener's Granulomatosis with Multiple Lower Cranial Nerve Palsies [PDF]

open access: gold, 2013
Sung-Hee Kim   +5 more
openalex   +1 more source

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

open access: yesMolecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy